This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Advocacy Remove Blood Pressure Remove Safety Remove Sleep
article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

DECEMBER 12, 2022

Hallucinations, increased blood pressure, nausea, vomiting, and diarrhea are all common side effects. Stage three lasts up to 72 hours after ingestion, and is characterized by mild stimulation, heightened awareness and disrupted sleep. Iboga safety: Numerous concerns about the safety of iboga have been raised by scientists.

History 119
History Microdosing Research and Development Clinical Trials 119
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40
Cannabinoids Marijuana Research and Development Access 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024